Al Khayyat Investments expands foray in mobile commerce with BinSina Pharmacy Arabic app
- Al Khayyat Investments appoints new management staff for its flagship model, BinSina Pharmacy, to speed up its MENA growth plans
Dubai, UAE: Al Khayyat Investments (AKI), one of many UAE’s outstanding family-owned conglomerates, is paving the best way for accelerated progress of its pharmacy enterprise in the MENA area, investing in each digital infrastructure and human capital.
AKI’s widespread BinSina Pharmacy model has unveiled an upgraded mobile app that provides Arabic-speaking prospects a flawless searching, ordering and supply monitoring expertise from wherever. The app already presents 6,000 particular person gadgets to shoppers and can scale to 10,000 over the subsequent six months. The pharmacy app is being made accessible in each English and Arabic in the UAE, with plans to roll out the app to extra markets quickly, following BinSina’s growth into Oman.
The transfer comes as analytics agency AppsFlyer notes that UAE companies are doubling down on mobile apps in a bid to extend buyer engagement and spending, with mobile app downloads in the UAE rising 23% year-on-year in the primary half of 2022 .
AKI sees potential in each e-commerce and brick-and-mortar retail, and has additionally assembled a brand new management staff to attain its growth ambitions. At the helm is business veteran Dr. Doaa Marouf, who was promoted to CEO of AKI Pharma and BinSina Pharmacy. Joining Marouf shall be Della Pass, who’s new to AKI and has joined as Senior GM of BinSina Pharmacy, in addition to overseeing the Holland & Barrett model inside AKI.
Zaid S. Al Khayyat, Managing Director of Al Khayyat Investments (AKI), says: “AKI has long been at the forefront of the pharmaceutical sector working with partners to not only bring the world’s best products to local communities, but to achieve innovative retail. models. Our latest investments in both people and infrastructure reflect our belief in always continuing to drive the market forward.”
“BinSina Pharmacy has been on an accelerated growth path in recent years, fueled in part by the latest digital infrastructure that helps us serve consumers anytime, anywhere,” provides Dr. Doaa Marouf, CEO of AKI Pharma and BinSina Apteek, at. “Together with a senior management team with many years of entrepreneurial experience, there is no limit to where we can go.”
AKI presently has a footprint throughout eight international locations in the broader Middle East and Africa area, coming into Saudi Arabia and Egypt in 2022.
– End-
About Al Khayyat Investments
Established in the UAE in 1982, Al Khayyat Investments (AKI) is a family-owned conglomerate thought of a pioneer in varied industries in the Middle East, delivering worthwhile partnerships by means of specialised operational experience. AKI enjoys continued progress throughout a number of sectors together with: distribution, retail, healthcare, contracting, health and leisure and automotive. While AKI is acknowledged as one of many area’s trusted enterprise companions for native and world companies, it is usually an revolutionary architect of wholly owned ideas in the retail sector.
AKI has grown exponentially over the previous 4 many years with greater than 5,500 staff representing greater than 54 nationalities.
For media inquiries, please contact:
Weber Shandwick MENAT
[email protected]
